BHV Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes (NCT02537470) | BHV Pharma | 2015-07-01 |
Track BHV Pharma automatically
Every clearance here is in the API, with alerts when new ones post.